461 related articles for article (PubMed ID: 30103348)
1. Centronuclear myopathies under attack: A plethora of therapeutic targets.
Tasfaout H; Cowling BS; Laporte J
J Neuromuscul Dis; 2018; 5(4):387-406. PubMed ID: 30103348
[TBL] [Abstract][Full Text] [Related]
2. Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances.
Gómez-Oca R; Cowling BS; Laporte J
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768808
[TBL] [Abstract][Full Text] [Related]
3. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
[TBL] [Abstract][Full Text] [Related]
4. Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.
Böhm J; Biancalana V; Malfatti E; Dondaine N; Koch C; Vasli N; Kress W; Strittmatter M; Taratuto AL; Gonorazky H; Laforêt P; Maisonobe T; Olivé M; Gonzalez-Mera L; Fardeau M; Carrière N; Clavelou P; Eymard B; Bitoun M; Rendu J; Fauré J; Weis J; Mandel JL; Romero NB; Laporte J
Brain; 2014 Dec; 137(Pt 12):3160-70. PubMed ID: 25260562
[TBL] [Abstract][Full Text] [Related]
5. Novel molecular diagnostic approaches for X-linked centronuclear (myotubular) myopathy reveal intronic mutations.
Tosch V; Vasli N; Kretz C; Nicot AS; Gasnier C; Dondaine N; Oriot D; Barth M; Puissant H; Romero NB; Bönnemann CG; Heller B; Duval G; Biancalana V; Laporte J
Neuromuscul Disord; 2010 Jun; 20(6):375-81. PubMed ID: 20434914
[TBL] [Abstract][Full Text] [Related]
6. X-linked myotubular and centronuclear myopathies.
Pierson CR; Tomczak K; Agrawal P; Moghadaszadeh B; Beggs AH
J Neuropathol Exp Neurol; 2005 Jul; 64(7):555-64. PubMed ID: 16042307
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic mechanisms in centronuclear myopathies.
Jungbluth H; Gautel M
Front Aging Neurosci; 2014; 6():339. PubMed ID: 25566070
[TBL] [Abstract][Full Text] [Related]
8. Centronuclear (myotubular) myopathy.
Jungbluth H; Wallgren-Pettersson C; Laporte J
Orphanet J Rare Dis; 2008 Sep; 3():26. PubMed ID: 18817572
[TBL] [Abstract][Full Text] [Related]
9. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen improves muscle structure and function of Bin1- and Dnm2-related centronuclear myopathies.
Gineste C; Simon A; Braun M; Reiss D; Laporte J
Brain; 2023 Jul; 146(7):3029-3048. PubMed ID: 36562127
[TBL] [Abstract][Full Text] [Related]
11. The cnm locus, a canine homologue of human autosomal forms of centronuclear myopathy, maps to chromosome 2.
Tiret L; Blot S; Kessler JL; Gaillot H; Breen M; Panthier JJ
Hum Genet; 2003 Sep; 113(4):297-306. PubMed ID: 12884002
[TBL] [Abstract][Full Text] [Related]
12. Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes.
Silva-Rojas R; Nattarayan V; Jaque-Fernandez F; Gomez-Oca R; Menuet A; Reiss D; Goret M; Messaddeq N; Lionello VM; Kretz C; Cowling BS; Jacquemond V; Laporte J
Mol Ther; 2022 Feb; 30(2):868-880. PubMed ID: 34371181
[TBL] [Abstract][Full Text] [Related]
13. Reducing dynamin 2 (DNM2) rescues
Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
[TBL] [Abstract][Full Text] [Related]
14. Common and variable clinical, histological, and imaging findings of recessive RYR1-related centronuclear myopathy patients.
Abath Neto O; Moreno CAM; Malfatti E; Donkervoort S; Böhm J; Guimarães JB; Foley AR; Mohassel P; Dastgir J; Bharucha-Goebel DX; Monges S; Lubieniecki F; Collins J; Medne L; Santi M; Yum S; Banwell B; Salort-Campana E; Rendu J; Fauré J; Yis U; Eymard B; Cheraud C; Schneider R; Thompson J; Lornage X; Mesrob L; Lechner D; Boland A; Deleuze JF; Reed UC; Oliveira ASB; Biancalana V; Romero NB; Bönnemann CG; Laporte J; Zanoteli E
Neuromuscul Disord; 2017 Nov; 27(11):975-985. PubMed ID: 28818389
[TBL] [Abstract][Full Text] [Related]
15. A Study of a Cohort of X-Linked Myotubular Myopathy at the Clinical, Histologic, and Genetic Levels.
Abath Neto O; Silva MR; Martins Cde A; Oliveira Ade S; Reed UC; Biancalana V; Pesquero JB; Laporte J; Zanoteli E
Pediatr Neurol; 2016 May; 58():107-12. PubMed ID: 26995067
[TBL] [Abstract][Full Text] [Related]
16. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.
Zhao Y; Zhao Z; Shen H; Bing Q; Hu J
Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666
[TBL] [Abstract][Full Text] [Related]
17. Novel SPEG Mutations in Congenital Myopathy without Centralized Nuclei.
Lornage X; Sabouraud P; Lannes B; Gaillard D; Schneider R; Deleuze JF; Boland A; Thompson J; Böhm J; Biancalana V; Laporte J
J Neuromuscul Dis; 2018; 5(2):257-260. PubMed ID: 29614691
[TBL] [Abstract][Full Text] [Related]
18. Myotubular/centronuclear myopathy and central core disease.
Fujimura-Kiyono C; Racz GZ; Nishino I
Neurol India; 2008; 56(3):325-32. PubMed ID: 18974559
[TBL] [Abstract][Full Text] [Related]
19. A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy.
Tosch V; Rohde HM; Tronchère H; Zanoteli E; Monroy N; Kretz C; Dondaine N; Payrastre B; Mandel JL; Laporte J
Hum Mol Genet; 2006 Nov; 15(21):3098-106. PubMed ID: 17008356
[TBL] [Abstract][Full Text] [Related]
20. SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs.
Pelé M; Tiret L; Kessler JL; Blot S; Panthier JJ
Hum Mol Genet; 2005 Jun; 14(11):1417-27. PubMed ID: 15829503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
